Company News
Kazia Therapeutics Raises $40M via Public Offering
Kazia Therapeutics ADR shares fell 6.2% in pre‑market after pricing a $15.50 per ADS public offering.
The company aims to raise about $40 million gross by selling 2.58 million ADS and issuing warrants
